AnaptysBio Inc buy Wells Fargo & Company
Start price
12.12.24
/
50%
€14.40
Target price
12.12.25
€38.17
Performance (%)
159.72%
End price
13.12.25
€37.40
Summary
This prediction ended on 13.12.25 with a price of €37.40. The BUY prediction by Wells_Fargo___Compan for AnaptysBio Inc saw massive gains of 159.72%. Wells_Fargo___Compan has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | -3.812% | -3.812% | 115.425% |
| iShares Core DAX® | 2,59 % | 2,47 % | 8,84 % |
| iShares Nasdaq 100 | -0,91 % | -6,46 % | 24,93 % |
| iShares Nikkei 225® | 0,15 % | -8,77 % | 47,39 % |
| iShares S&P 500 | -0,37 % | -1,22 % | 21,67 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Wells Fargo & Company from $56.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten